Document is current

Any future updates will be listed below

What do we know about treatment sequencing of abiraterone, enzalutamide, and chemotherapy in metastatic castration-resistant prostate cancer?

Crossref DOI link: https://doi.org/10.1007/s00345-015-1687-0

Published Online: 2015-09-15

Published Print: 2016-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark